Furthermore, the evaluation of the effect of isoalantolactone treatment on the MEK1 pathway, which is associated with ERK signaling and cisplatin resistance in cancer cells [23], revealed that isoalantolactone increased MEK1 phosphorylation (Figure 4C). This evidence concerns the gene MAP2K1 and cancer.